Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1991-10-4
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0954-6111
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
85
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
169-70
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1887135-Administration, Inhalation,
pubmed-meshheading:1887135-Albuterol,
pubmed-meshheading:1887135-Asthma,
pubmed-meshheading:1887135-Bronchodilator Agents,
pubmed-meshheading:1887135-Drug Administration Schedule,
pubmed-meshheading:1887135-Ethanolamines,
pubmed-meshheading:1887135-Humans
|
pubmed:year |
1991
|
pubmed:articleTitle |
The use of inhaled formoterol in asthma.
|
pubmed:publicationType |
Letter,
Comment
|